In 2026, the conversation around AI in HR will finally shift from “What if…?” to “What now?”  The rise of AI has pushed HR ...

GUEST OPINION: 2025 was the year every board demanded an AI strategy. In 2026, they will demand results. After more than a year of pilots and experiments, most businesses have observed marginal gains ...

By 2026, we’ll reach peak value from publicly available data, as AI models extract the last drops of signal from the open internet. The next wave of AI progress will depend as much on discovering ...

Australian biotech innovator Vaxxas has secured a major milestone in its journey to revolutionise vaccine delivery. The company has been granted approval by the Therapeutic Goods Administration (TGA) ...

Australian biotech innovator Vaxxas has secured a major milestone in its journey to revolutionise vaccine delivery. The company has been granted approval by the Therapeutic Goods Administration (TGA) ...

Australian biotech innovator Vaxxas has secured a major milestone in its journey to revolutionise vaccine delivery. The company has been granted approval by the Therapeutic Goods Administration (TGA) ...

Australian biotech innovator Vaxxas has secured a major milestone in its journey to revolutionise vaccine delivery. The company has been granted approval by the Therapeutic Goods Administration (TGA) ...

In 2026, success in Australia will belong to businesses that can move as fast as the technology they depend on. The themes of the year – AI agility, data sovereignty, subscription-first models, and ...

Last year, AI was the big experiment. Businesses were throwing it at everything to see what stuck. Today, it is the centre of corporate strategy. As businesses laser in on what’s working, it’s ...

Last year, AI was the big experiment. Businesses were throwing it at everything to see what stuck. Today, it is the centre of corporate strategy. As businesses laser in on what’s working, it’s ...